Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong · Delayed Price · Currency is HKD 1.820
-0.070 (-3.70%)
Sep 18, 2026, 4:08 PM HKT
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 898.73 million as of September 18, 2026. Its market cap has decreased by -24.01% in one year.
Market Cap
898.73M
Enterprise Value
1.02B
Revenue
90.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.82
ChartMarket Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 898.73M, a decrease of -88.68%. That is a compound annual growth rate of -29.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 898.73M | -7.09% |
| Dec 31, 2025 | 967.31M | 130.32% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhaoke Ophthalmology | 1.37B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.35B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.30B |
| TYK Medicines | 1.25B |
| CANbridge Pharmaceuticals | 1.20B |
| Cloudbreak Pharma | 1.01B |
| Sunho Biologics | 970.43M |
| JW (Cayman) Therapeutics Co. | 892.97M |